✦ LIBER ✦

Single agent oral topotecan (OT) as first-line treatment for patients (pts) with extensive disease (ED) small cell lung cancer (SCLC) ineligible for standard therapy: A phase II study

✍ Scribed by Eckardt, J.R; Palmer, M.C; Fanucchi, M.P; Gralla, R; Martins, H; Poulin, R; Fields, S.Z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I/II study using oral topotecan

✍ Eckardt, J.R; Fanucchi, M.P; Stewart, D.J; Beckman, R.A; Dobbs, T.W; Wilson, J.J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 121 KB

A phase I/II study using oral topotecan

✍ Eckardt, J.R; Fanucchi, M.P; Stewart, D.J; Beckman, R.A; Dobbs, T.W; Wilson, J.J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Weekly cisplatin-paclitaxel-topotecan (C

✍ Frasci, G; Comella, P; Panza, N; Nicolella, G; Natale, M; De Cataldis, G; Carrec 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 119 KB

A phase II study testing paclitaxel as s

✍ Sculier, J.P.; Berghmans, T.; Lafitte, J.J.; Richez, M.; Recloux, P.; Van Cutsem 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Phase II study of maintenance sunitinib

✍ Spigel, David R.; Greco, F. Anthony; Rubin, Mark S.; Shipley, Dianna; Thompson, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 407 KB

Randomised phase II study of amrubicin a

✍ Mary E.R. O’Brien; Krzystof Konopa; Paul Lorigan; Lionel Bosquee; Ernest Marshal 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 277 KB